{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:52:54Z","timestamp":1794073974700,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41401-025-01635-2","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:28:16Z","timestamp":1755844096000},"page":"162-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors"],"prefix":"10.1038","volume":"47","author":[{"given":"Yi-min","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-ning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Eric","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"1635_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bl\u00fcher","year":"2019","unstructured":"Bl\u00fcher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"1635_CR2","doi-asserted-by":"crossref","unstructured":"Artasensi A, Pedretti A, Vistoli G, Fumagalli L. Type 2 diabetes mellitus: a review of multi-target drugs. Molecules. 2020;25:1987.","DOI":"10.3390\/molecules25081987"},{"key":"1635_CR3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038\u201348.","journal-title":"Metabolism"},{"key":"1635_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28683-0","volume":"13","author":"F Zhao","year":"2022","unstructured":"Zhao F, Zhou Q, Cong Z, Hang K, Zou X, Zhang C, et al. Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. Nat Commun. 2022;13:1057.","journal-title":"Nat Commun"},{"key":"1635_CR5","doi-asserted-by":"crossref","unstructured":"Er\u017een S, Tonin G, Juri\u0161i\u0107 Er\u017een D, Klen J. Amylin, another important neuroendocrine hormone for the treatment of diabesity. Int J Mol Sci 2024;25:1517.","DOI":"10.3390\/ijms25031517"},{"key":"1635_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/BF00404025","volume":"34","author":"E Hartter","year":"1991","unstructured":"Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, et al. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia. 1991;34:52\u20134.","journal-title":"Diabetologia"},{"key":"1635_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2337\/diab.39.6.752","volume":"39","author":"PC Butler","year":"1990","unstructured":"Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes. 1990;39:752\u20136.","journal-title":"Diabetes"},{"key":"1635_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/bs.apha.2020.01.001","volume":"88","author":"AA Pioszak","year":"2020","unstructured":"Pioszak AA, Hay DL. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors. Adv Pharmacol. 2020;88:115\u201341.","journal-title":"Adv Pharmacol"},{"key":"1635_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2174\/13892037113149990058","volume":"14","author":"K Kuwasako","year":"2013","unstructured":"Kuwasako K, Hay DL, Nagata S, Murakami M, Kitamura K, Kato J. Functions of third extracellular loop and helix 8 of Family B GPCRs complexed with RAMPs and characteristics of their receptor trafficking. Curr Protein Pept Sci. 2013;14:416\u201328.","journal-title":"Curr Protein Pept Sci"},{"key":"1635_CR10","doi-asserted-by":"publisher","first-page":"8686","DOI":"10.1074\/jbc.M115.713628","volume":"291","author":"SM Lee","year":"2016","unstructured":"Lee SM, Hay DL, Pioszak AA. Calcitonin and amylin receptor peptide interaction mechanisms: insights into peptide-binding modes and allosteric modulation of the calcitonin receptor by receptor activity-modifying proteins. J Biol Chem. 2016;291:8686\u2013700.","journal-title":"J Biol Chem"},{"key":"1635_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.617400","volume":"11","author":"DS Mathiesen","year":"2020","unstructured":"Mathiesen DS, Lund A, Vilsb\u00f8ll T, Knop FK, Bagger JI. Amylin and calcitonin: potential therapeutic strategies to reduce body weight and liver fat. Front Endocrinol (Lausanne). 2020;11:617400.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1635_CR12","first-page":"203","volume":"2","author":"G Ryan","year":"2009","unstructured":"Ryan G, Briscoe TA, Jobe L. Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes. Drug Des Devel Ther. 2009;2:203\u201314.","journal-title":"Drug Des Devel Ther"},{"key":"1635_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.clinthera.2005.10.009","volume":"27","author":"GJ Ryan","year":"2005","unstructured":"Ryan GJ, Jobe LJ, Martin R. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus. Clin Ther. 2005;27:1500\u201312.","journal-title":"Clin Ther"},{"key":"1635_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2019.00155","volume":"10","author":"LB Knudsen","year":"2019","unstructured":"Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol (Lausanne). 2019;10:155.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1635_CR15","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","volume":"398","author":"DCW Lau","year":"2021","unstructured":"Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet. 2021;398:2160\u201372.","journal-title":"Lancet"},{"key":"1635_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/CRD.0000000000000513","volume":"32","author":"AM D\u2019Ascanio","year":"2024","unstructured":"D\u2019Ascanio AM, Mullally JA, Frishman WH. Cagrilintide: a long-acting amylin analog for the treatment of obesity. Cardiol Rev. 2024;32:83\u201390.","journal-title":"Cardiol Rev"},{"key":"1635_CR17","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(21)00845-X","volume":"397","author":"LB Enebo","year":"2021","unstructured":"Enebo LB, Berthelsen KK, Kankam M, Lund MT, Rubino DM, Satylganova A, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2\u00b74 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021;397:1736\u201348.","journal-title":"Lancet"},{"key":"1635_CR18","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1021\/acs.jmedchem.1c00565","volume":"64","author":"T Kruse","year":"2021","unstructured":"Kruse T, Hansen JL, Dahl K, Schaffer L, Sensfuss U, Poulsen C, et al. Development of cagrilintide, a long-acting amylin analogue. J Med Chem. 2021;64:11183\u201394.","journal-title":"J Med Chem"},{"key":"1635_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","volume":"402","author":"JP Frias","year":"2023","unstructured":"Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, et al. Efficacy and safety of co-administered once-weekly cagrilintide 2\u00b74 mg with once-weekly semaglutide 2\u00b74 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023;402:720\u201330.","journal-title":"Lancet"},{"key":"1635_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/jim-2021-001952","volume":"70","author":"G Singh","year":"2022","unstructured":"Singh G, Krauthamer M, Bjalme-Evans M. Wegovy (semaglutide): a new weight loss drug for chronic weight management. J Investig Med. 2022;70:5\u201313.","journal-title":"J Investig Med"},{"key":"1635_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm9609","volume":"375","author":"J Cao","year":"2022","unstructured":"Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, et al. A structural basis for amylin receptor phenotype. Science. 2022;375:eabm9609.","journal-title":"Science"},{"key":"1635_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41589-023-01393-4","volume":"20","author":"J Cao","year":"2024","unstructured":"Cao J, Belousoff MJ, Gerrard E, Danev R, Fletcher MM, Dal Maso E, et al. Structural insight into selectivity of amylin and calcitonin receptor agonists. Nat Chem Biol. 2024;20:162\u20139.","journal-title":"Nat Chem Biol"},{"key":"1635_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/acsptsci.8b00056","volume":"2","author":"E Dal Maso","year":"2019","unstructured":"Dal Maso E, Glukhova A, Zhu Y, Garcia-Nafria J, Tate CG, Atanasio S, et al. The molecular control of calcitonin receptor signaling. ACS Pharmacol Transl Sci. 2019;2:31\u201351.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1635_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature22327","volume":"546","author":"YL Liang","year":"2017","unstructured":"Liang YL, Khoshouei M, Radjainia M, Zhang Y, Glukhova A, Tarrasch J, et al. Phase-plate cryo-EM structure of a class B GPCR-G-protein complex. Nature. 2017;546:118\u201323.","journal-title":"Nature"},{"key":"1635_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1126\/science.aav7942","volume":"364","author":"LH Zhao","year":"2019","unstructured":"Zhao LH, Ma S, Sutkeviciute I, Shen DD, Zhou XE, de Waal PW, et al. Structure and dynamics of the active human parathyroid hormone receptor-1. Science. 2019;364:148\u201353.","journal-title":"Science"},{"key":"1635_CR26","doi-asserted-by":"publisher","first-page":"e0175642","DOI":"10.1371\/journal.pone.0175642","volume":"12","author":"R Nehm\u00e9","year":"2017","unstructured":"Nehm\u00e9 R, Carpenter B, Singhal A, Strege A, Edwards PC, White CF, et al. Mini-G proteins: Novel tools for studying GPCRs in their active conformation. PLoS One. 2017;12:e0175642.","journal-title":"PLoS One"},{"key":"1635_CR27","doi-asserted-by":"crossref","unstructured":"Zhao LH, Yuan QN, Dai AT, He XH, Chen CW, Zhang C, et al. Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1. Acta Pharmacol Sin. 2023;44:1227\u201337.","DOI":"10.1038\/s41401-022-01032-z"},{"key":"1635_CR28","doi-asserted-by":"crossref","unstructured":"Zhao LH, He Q, Yuan Q, Gu Y, He X, Shan H, et al. Conserved class B GPCR activation by a biased intracellular agonist. Nature. 2023;621:635\u201341.","DOI":"10.1038\/s41586-023-06467-w"},{"key":"1635_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng SQ, Palovcak E, Armache JP, Verba KA, Cheng Y, Agard DA. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14:331\u20132.","journal-title":"Nat Methods"},{"key":"1635_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou A, Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J Struct Biol. 2015;192:216\u201321.","journal-title":"J Struct Biol"},{"key":"1635_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1107\/S2052252520000081","volume":"7","author":"J Zivanov","year":"2020","unstructured":"Zivanov J, Nakane T, Scheres SHW. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ. 2020;7:253\u201367.","journal-title":"IUCrJ"},{"key":"1635_CR32","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Computat Chem. 2004;25:1605\u201312.","journal-title":"J Computat Chem"},{"key":"1635_CR33","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126\u201332.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1635_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66:213\u201321.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1635_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk5184","volume":"10","author":"JJ Wang","year":"2024","unstructured":"Wang JJ, Jin S, Zhang H, Xu Y, Hu W, Jiang Y, et al. Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs. Sci Adv. 2024;10:eadk5184.","journal-title":"Sci Adv"},{"key":"1635_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33851-3","volume":"13","author":"LH Zhao","year":"2022","unstructured":"Zhao LH, Lin J, Ji SY, Zhou XE, Mao C, Shen DD, et al. Structure insights into selective coupling of G protein subtypes by a class B G protein-coupled receptor. Nat Commun. 2022;13:6670.","journal-title":"Nat Commun"},{"key":"1635_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tips.2013.11.001","volume":"35","author":"K Hollenstein","year":"2014","unstructured":"Hollenstein K, de Graaf C, Bortolato A, Wang MW, Marshall FH, Stevens RC. Insights into the structure of class B GPCRs. Trends Pharmacol Sci. 2014;35:12\u201322.","journal-title":"Trends Pharmacol Sci"},{"key":"1635_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58680-y","volume":"16","author":"J Cao","year":"2025","unstructured":"Cao J, Belousoff MJ, Johnson RM, Keov P, Mariam Z, Deganutti G, et al. Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors. Nat Commun. 2025;16:3389.","journal-title":"Nat Commun"},{"key":"1635_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17791-4","volume":"11","author":"M Dong","year":"2020","unstructured":"Dong M, Deganutti G, Piper SJ, Liang YL, Khoshouei M, Belousoff MJ, et al. Structure and dynamics of the active Gs-coupled human secretin receptor. Nat Commun. 2020;11:4137.","journal-title":"Nat Commun"},{"key":"1635_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.molcel.2020.01.013","volume":"77","author":"S Ma","year":"2020","unstructured":"Ma S, Shen Q, Zhao LH, Mao C, Zhou XE, Shen DD, et al. Molecular basis for hormone recognition and activation of corticotropin-releasing factor receptors. Mol Cell. 2020;77:669\u201380.e4.","journal-title":"Mol Cell"},{"key":"1635_CR41","doi-asserted-by":"crossref","unstructured":"Josephs TM, Belousoff MJ, Liang YL, Piper SJ, Cao J, Garama DJ, et al. Structure and dynamics of the CGRP receptor in apo and peptide-bound forms. Science. 2021;372:eabf7258.","DOI":"10.1126\/science.abf7258"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01635-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01635-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01635-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:22:30Z","timestamp":1767424950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01635-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1635"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01635-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}